Ibaraki, Japan

Toshihiro Noguchi



Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Ibaraki, JP (2006 - 2010)
  • Oklahoma City, OK (US) (2011)
  • Osaka, JP (2012 - 2015)

Company Filing History:


Years Active: 2006-2015

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Toshihiro Noguchi

Introduction

Toshihiro Noguchi is a prominent inventor based in Ibaraki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. With a total of 6 patents to his name, Noguchi's work has the potential to impact the lives of many patients.

Latest Patents

Among his latest patents, one notable invention is a medicament for the treatment of cancer. This medicament is designed for use in combination therapy with an anti-HER2 antibody and comprises amrubicin or a pharmaceutically acceptable salt thereof as an active ingredient. Another significant patent focuses on treating lung cancer effectively by combining amrubicin or a pharmaceutically acceptable salt thereof with cisplatin. These innovations highlight Noguchi's commitment to advancing cancer therapies.

Career Highlights

Throughout his career, Toshihiro Noguchi has worked with reputable companies such as Dainippon Sumitomo Pharma Co., Ltd. and Sumitomo Pharmaceuticals Company Limited. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical industry.

Collaborations

Noguchi has collaborated with several talented individuals in his field, including Akemi Baba and Mitsuharu Hanada. These partnerships have contributed to the success of his projects and the advancement of cancer treatment options.

Conclusion

Toshihiro Noguchi's contributions to cancer treatment through his innovative patents demonstrate his dedication to improving healthcare. His work continues to inspire future advancements in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…